24 Oct CLSI has provided testing and interpretive criteria for common organisms. • Labs occasionally need to test “infrequently isolated or fastidious”. 15 Aug Home; CLSI M45 Clinical and Laboratory Standards Institute document M Methods for Antimicrobial Dilution and Disk CLSI MA2. D(ABMM) Thomas R. CLSI document MA2 (ISBN ).clsi. contact us at: Telephone: West Valley Road. in vitro antimicrobial.

Author: Gardashura Kazill
Country: Burundi
Language: English (Spanish)
Genre: Environment
Published (Last): 26 February 2008
Pages: 289
PDF File Size: 12.31 Mb
ePub File Size: 10.37 Mb
ISBN: 504-9-85763-434-6
Downloads: 11983
Price: Free* [*Free Regsitration Required]
Uploader: Jusar

Close mobile search navigation Article navigation. The methods described are generic reference methods that can be used for routine susceptibility clsi m45-a2 by most clinical laboratories.

Our policy towards clsi m45-a2 use of cookies Techstreet, a Clarivate Analytics brand, uses cookies to improve mm45-a2 online experience. It also includes a series of procedures designed to standardize test performance.

For some of the organisms, a disk diffusion method is described, and this method can be easily adopted by most clinical laboratories performing clsi m45-a2 diffusion testing. In such cases, in vitro antimicrobial susceptibility of clsi m45-a2 organism isolated is most likely indicated.

Full Description If a bacterial pathogen’s susceptibility to antimicrobial agents cannot be predicted based on the identity of the organism alone, in vitro antimicrobial susceptibility testing of the isolated organism may be indicated. Jorgenson stresses the importance cldi clsi m45-a2 their distinction from M However, there are instances in which the sensitivity clsi m45-a2 such a pathogen cannot be predicted simply based on the identity of the organism.

You can change your cookie settings through your browser. Prompt, accurate identification of a bacterial pathogen is one of the most valuable services the microbiology laboratory provides for clinicians in its efforts to positively impact patient care. Jorgensen offers an example of how this guideline might be used in a typical laboratory. Clsi m45-a2 performance, applications, and limitations of the current CLSI-recommended methods are described.


Clsi m45-a2 Experts James H. Interested facilities should contact CLSI for more information, including purchasing options, on this essential document. M45 does not suggest that laboratories test all infrequently encountered or fastidious isolates, especially if they are of dubious clinical significance, Dr. While comprehensive, the guideline is not prescriptive, clai allows some degree of clsi m45-a2 of criteria and policies clsi m45-a2 each laboratory and its medical staff.

M45 addresses the modifications required to test these organisms and provides expert guidance on how to interpret results, including identifying the essential breakpoints.

— Page Not Found

Receive exclusive offers and updates from Oxford Academic. CLSI is a global, nonprofit organization that clsi m45-a2 the development and use of clsk consensus standards and guidelines within the health care community.

However, in cases m455-a2 as those involving fastidious and infrequently isolated organisms for which specific guidelines do not exist, laboratorians have resorted to various alternative methods and applied breakpoints clsi m45-a2 other groups of organisms. They were placed on your computer when you launched this website. Clsi m45-a2 testing is especially necessary if the etiological agent is clsi m45-a2, or possibly resistant, to a commonly used antimicrobial agent.

Jorgensen and Hindler both agree that this revised guideline is very timely, in light of the increasingly common challenges faced by laboratories performing susceptibility testing on these organisms, including increased pressure from clinicians to provide susceptibility data quickly, and cli need for reliable clsi m45-a2 to identify emerging resistance.

These methods may also be used to evaluate commercial devices for routine use. Citing articles via Google Scholar. Jorgensen, PhD, chairholder of the CLSI working group that developed the document, it has long been accepted that for the most effective management of bacterial infections, laboratories must be able to determine susceptibility or resistance to therapeutic agents.



Therefore, laboratories need specific guidelines on how to perform valid susceptibility testing without using the US Food and Drug Administration FDA -cleared instrumentation and commercial test systems found in most laboratories. It furthers the Clsi m45-a2 objective of excellence in research, scholarship, and education clsi m45-a2 publishing worldwide. Oxford University Press is a department of the University of Oxford. Susceptibility testing is particularly necessary in those situations in which the etiological agent belongs to a bacterial species for which resistance to commonly used antimicrobial agents has been documented, or could arise.

Related articles in Google Scholar. Commercial susceptibility testing devices are not specifically addressed by M View all product details. However, clinicians need prompt guidance on treating organisms that clsi m45-a2 cause serious, life-threatening infections eg, bacteremia, endocarditis, and meningitis.

Popular Publishers

Before the publication of this guideline, a review of the literature revealed very clsi m45-a2 systematic studies on testing these organisms, Dr. Sign In clsi m45-a2 Create an Account. A variety of laboratory techniques can clsi m45-a2 used to measure the in vitro susceptibility of bacteria to antimicrobial agents.

According to James H. Its encompassing nature establishes M45 as an clsi m45-a2 resource to various constituencies, including the clinical laboratory. These organisms include Helicobacter cclsiVibrio choleraeand potential agents of bioterrorism, adds Hindler.

Jorgensen theorizes that diagnostic device companies may even modify their products to gain regulatory eg, FDA clearance for marketing to clinical laboratories.